[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Bayer Ag ADR (BAYRY)

Bayer Ag ADR (BAYRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 55,491,600
  • Shares Outstanding, K 3,930,000
  • Annual Sales, $ 51,564 M
  • Annual Income, $ -4,096 M
  • EBIT $ 448 M
  • EBITDA $ 1,932 M
  • 60-Month Beta 0.56
  • Price/Sales 1.09
  • Price/Cash Flow 6.53
  • Price/Book 1.65
  • Price/Earnings ttm 9.97
  • Earnings Per Share ttm 1.43
  • Most Recent Earnings $0.29 on 08/04/26
  • Next Earnings Date 11/11/26
  • Annual Dividend & Yield (Fwd) 0.02 (0.17%)
  • Most Recent Dividend 0.024 on 04/28/26
  • Sector Medical
  • INDUSTRY GROUPING Large Cap Pharma

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.13
  • Number of Estimates 2
  • High Estimate $0.16
  • Low Estimate $0.10
  • Prior Year $0.17
  • Growth Rate Est. (year over year) -23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.5200 +5.55%
on 08/03/26
14.6000 -2.26%
on 08/07/26
+0.3800 (+2.74%)
since 07/31/26
3-Month
9.8448 +44.95%
on 06/03/26
15.2300 -6.30%
on 07/02/26
+4.3900 (+44.43%)
since 06/02/26
52-Week
7.4790 +90.80%
on 11/04/25
15.2300 -6.30%
on 07/02/26
+6.2700 (+78.38%)
since 09/02/25

Most Recent Stories

More News
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

Phase III results in patients with suspected cardiac amyloidosis were presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The Journal of the American...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026

Presentations include investigational late-breaking KERENDIA ® (finerenone) data in chronic kidney disease (CKD), including a pooled analysis from studies in patients with and without diabetes...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
LYNKUET® (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer

Expanded authorization introduces a treatment option for women experiencing moderate to severe hot flashes and/or night sweats caused by adjuvant endocrine therapy (AET) related to breast cancer ...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin

New Formula Delivers Daily Nutritional Support for Hair, Skin and Nails* Key Facts One A Day® Women's Multi Gummy vitamins...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters

New research by Economist Enterprise, supported by Bayer, highlights the potential of self-care to become a more integrated component of modern health systems The research underscores...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months Autonomy technology is designed to lower capital expenditures and...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials

Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart

One A Day®, the multivitamin and supplement brand from Bayer, has partnered with country superstar and five time Entertainer of the Year Luke Bryan to launch a limited edition multivitamin bottle featuring...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon

Advances key component of Crop Science division’s Five-Year Framework strategy Reinforces commitment to delivering trusted Roundup ® brands and glyphosate...

BAYRY : 14.2550 (+0.96%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses....

See More

Key Turning Points

3rd Resistance Point 14.3933
2nd Resistance Point 14.3067
1st Resistance Point 14.2133
Last Price 14.2550
1st Support Level 14.0333
2nd Support Level 13.9467
3rd Support Level 13.8533

See More

52-Week High 15.2300
Last Price 14.2550
Fibonacci 61.8% 12.2691
Fibonacci 50% 11.3545
Fibonacci 38.2% 10.4399
52-Week Low 7.4790

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.